The New York Times reports a children's cancer drug could soon run out at the nation's hospitals.
The drug is called Methotrexate and it's used to treat leukemia.
It's also used to used to treat rheumatoid arthritis.
The FDA says the situation is quote dire.
One of the reasons supply is so low right now is because a major supplier suspended operations.
The company apparently had significant manufacturing and quality concerns, the Times reports.
Other manufacturers say they are attempting to up their production of the drug.